Prevalence of Hypogonadism in Low-Risk Prostate Cancer Survivors.
Year: 2016
Type: article
Abstract: Increasing evidence, albeit small, suggests that testosterone replacement therapy can be cautiously considered in selected hypogonadal men treated with curative intent for low-risk prostate cancer and without evidence of active disease.
Source: Europe PMC (PubMed Central)
Institutions: Edward Hines, Jr. VA Hospital, Loyola Medicine
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3024094522
